Sanofi’s New CEO Brandicourt Will Face Diabetes And Launch Challenges

But analysts say Olivier Brandicourt’s breadth of experience and cardiology strengths bode well for Sanofi, which can now close an unpleasant and very public boardroom shakeup and get on with needed business.